507 results
Page 4 of 26
8-K
EX-99.1
lxlp97d
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
5ftgaev 71giiromfac
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
eod1iyx
30 Oct 20
Ligand Reports Third Quarter 2020 Financial Results
8:03am
8-K
EX-99.1
gphm6uo70xr q3h28jhw
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
jpw1yx2 wleuyx9
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.1
kb1uizr1m
1 Oct 20
Contingent Value Rights Agreement
8:42am
8-K
EX-10.1
3douhbgwqc9nmi 3ys
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
9ro6qlwvkrvvpy6ju
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
bc754ghd6l
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
jewof0
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
n1lfs
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
unga33ymywj94ln
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-99.1
yq5m1chw pu3
10 Aug 20
Information about tender offer
9:52pm
SC TO-C
EX-99.2
cp778oe
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-2.1
h26jgejv xsr
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-99.1
zlancrz
10 Aug 20
Information about tender offer
9:50pm